Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
EGFR tyrosine kinase inhibitor resistance | R-ALL-1216523 | map01521 | Cetuximab | None | gdsc |
DNA replication | R-HSA-69306 | map03030 | Cisplatin | 131819891 | gdsc |
Ras signaling pathway | R-HSA-168638 | map04014 | Crizotinib | 11626560 | gdsc |
DNA replication | R-HSA-69306 | map03030 | Cyclophosphamide | 5359 | gdsc |
Metabolism | R-HSA-1430728 | 0 | DMOG | 52925779 | gdsc |
MAPK signaling pathway | R-HSA-9652817 | map04010 | Dabrafenib | 44462760 | gdsc |
Chromatin histone acetylation | R-HSA-156582 | 0 | Dacinostat | 52925780 | gdsc |
PI3K-Akt signaling pathway | R-HSA-168638 | map04151 | Dactolisib | 11977753 | gdsc |
Metabolism | R-HSA-1430728 | 0 | Daporinad | 41781 | gdsc |
Ras signaling pathway | R-HSA-168638 | map04014 | Dasatinib | 3062316 | gdsc |
EGFR tyrosine kinase inhibitor resistance | R-ALL-1216523 | map01521 | Dasatinib | 3062316 | gdsc |
Cell cycle | R-HSA-1640170 | map04110 | Dinaciclib | 46926350 | gdsc |
Mitosis | R-HSA-8854050 | 0 | Docetaxel | 148124 | gdsc |
MAPK signaling pathway | R-HSA-9652817 | map04010 | Doramapimod | 156422 | gdsc |
DNA replication | R-HSA-69306 | map03030 | Doxorubicin | 4044 | gdsc |
EGFR tyrosine kinase inhibitor resistance | R-ALL-1216523 | map01521 | Dyrk1b_0191 | None | gdsc |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | EHT-1864 | 131819892 | gdsc |
Chromatin histone methylation | R-HSA-156581 | 0 | EPZ004777 | 52925781 | gdsc |
Chromatin histone methylation | R-HSA-156581 | 0 | EPZ5676 | 52925783 | gdsc |
MAPK signaling pathway | R-HSA-9652817 | map04010 | ERK_2440 | None | gdsc |